MedPath

Comparison of Frequency of Use of Optive and Systane

Phase 4
Completed
Conditions
Dry Eye
Registration Number
NCT00406510
Lead Sponsor
Innovative Medical
Brief Summary

The purpose of this study is subjectively compare duration of action between Optive and Systane.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Males or females > 18 years old
  • Mild to moderate dry eye symptoms
  • Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
  • Likely to complete all study visits and able to provide informed consent
Exclusion Criteria
  • Current use of topical cyclosporine
  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
  • Ocular surgery within the past 3 months,
  • Active ocular allergies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Private Practice

🇺🇸

Azusa, California, United States

© Copyright 2025. All Rights Reserved by MedPath